Article info
PDFReview
The posterior reversible encephalopathy syndrome: what's certain, what's new?
- Correspondence to Dr C Roth, Department of Neurology, Klinikum Kassel, Moenchebergstraße 41–43, 34125 Kassel, Germany; roth99{at}web.de
Citation
The posterior reversible encephalopathy syndrome: what's certain, what's new?
Publication history
- First published May 5, 2011.
Online issue publication
February 19, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Posterior reversible encephalopathy syndrome (PRES): diagnosis and management
- Cerebral-autoregulatory dysfunction syndrome
- Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
- Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment
- Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement
- An unusual cause of altered mental status: the importance of monitoring a patient's blood pressure
- Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion
- Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine
- Posterior reversible encephalopathy syndrome: long-term follow-up
- Posterior reversible encephalopathy syndrome resulting from repeat bortezomib usage